CapsoVision ROE 1971-1970 | CV
Current and historical return on equity (ROE) values for CapsoVision (CV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| CapsoVision ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.197B | $0.000B |
| CapsoVision Inc. is a commercial-stage medical technology company which develops advanced imaging and artificial intelligence technologies which are deployed in its capsule endoscopy solutions. CapsoVision Inc. is based in SARATOGA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.738B | 59.46 |
| Hims & Hers Health (HIMS) | United States | $12.987B | 134.93 |
| Doximity (DOCS) | United States | $11.457B | 53.04 |
| Tempus AI (TEM) | United States | $11.228B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.298B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.880B | 60.62 |
| Hinge Health (HNGE) | United States | $3.671B | 0.00 |
| Privia Health (PRVA) | United States | $2.475B | 169.17 |
| Clover Health Investments (CLOV) | United States | $1.735B | 0.00 |
| Schrodinger (SDGR) | United States | $1.690B | 0.00 |
| 10x Genomics (TXG) | United States | $1.677B | 0.00 |
| Phreesia (PHR) | United States | $1.648B | 0.00 |
| Enovis (ENOV) | United States | $1.582B | 8.82 |
| Azenta (AZTA) | United States | $1.578B | 73.36 |
| Omnicell (OMCL) | United States | $1.321B | 23.31 |
| Evolent Health (EVH) | United States | $1.199B | 102.10 |
| Claritev (CTEV) | United States | $0.719B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.575B | 0.00 |
| Standard BioTools (LAB) | United States | $0.551B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.532B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Talkspace (TALK) | United States | $0.438B | 131.00 |
| TruBridge (TBRG) | United States | $0.347B | 770.33 |
| Outset Medical (OM) | United States | $0.345B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.282B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.265B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.176B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.164B | 0.00 |
| Pulmonx (LUNG) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.134B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.122B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 3.98 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.086B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.083B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |